A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
The body of Blackwood grandmother has been repatriated to the UK, along with eight other victims of the Tunisian beach massacre.
It feels much fresher out there than it has done recently. So hopefully a much more comfortable night's sleep all round.
Shadow Welsh Secretary criticises timing clash for denying Welsh MPs the chance to debate controversial English veto